STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
AUPH AURINIA PHARMACEUTICALS INCORPORATED StockScouter® Report
3
StockScouter® Score
AURINIA PHARMACEUTICALS INCORPORATED, a small cap growth company in the healthcare sector, is expected to slightly underperform the market over the next six months with average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
Concerns
- The most recent quarterly earnings report was significantly lower than analysts’ consensus forecast. Negative
- Two or more executives, board directors or major shareholders – including one high-level executive -- sold a large number of shares recently. Very negative
- The multi-period measure of relative price change and consistency is well below average. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be out of favor, growth stocks will be out of favor, and healthcare stocks will be out of favor.
Expected Risk/Return
Core Model Grades
D
F
C
F